More articles from Clinical Investigations (Human)

Open Access
Lessons learned from post-COVID-19 vaccination PET/CT studies
Marina Orevi, Alexandre Chicheportiche and Simona Ben-Haim

Journal of Nuclear Medicine July 22, 2021, jnumed.121.262348; DOI: https://doi.org/10.2967/jnumed.121.262348
You have access
Functional characterization of adrenocortical masses in nononcological patients using [⁶⁸Ga]-pentixafor
Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li

Journal of Nuclear Medicine July 22, 2021, jnumed.121.261964; DOI: https://doi.org/10.2967/jnumed.121.261964
You have access
Evaluation of Deep Learning-based Approaches to Segment Bowel Air Pockets and Generate Pelvis Attenuation Maps from CAIPIRINHA-accelerated Dixon MR Images
Hasan Sari, Ja Reaungamornrat, Onofrio Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel Antonio Morales, Angel Torrado-Carvajal, Sheung Chee Thomas Ng, Norberto Malpica, Ali Kamen and Ciprian Catana

Journal of Nuclear Medicine July 22, 2021, jnumed.120.261032; DOI: https://doi.org/10.2967/jnumed.120.261032
You have access
First-in-human study of ⁸⁹Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer
Anna-Larissa Nadia Niemeijer, Daniela E Oprea Lager, Marc C Huisman, Otto S Hoekstra, Ronald Boellaard, Berlinda van de Veen, Idris Bahce, Danielle J Vugts, Guus AMS van Dongen, Erik Thunnissen, Egbert Smit and Adrianus J. de Langen

Journal of Nuclear Medicine July 22, 2021, jnumed.121.261926; DOI: https://doi.org/10.2967/jnumed.121.261926
You have access
A Path to Qualification of PET/MR Scanners for Multicenter Brain Imaging Studies: Evaluation of MR-based Attenuation Correction Methods Using a Patient Phantom
Ciprian Catana, Richard Laforest, Hongyu An, Fernando Boada, Tuoyu Cao, David Faul, Bjoern Jakoby, Floris P Jansen, Brad J Kemp, Paul E. Kinahan, Peder E. Z. Larson, Michael A Levine, Piotr Maniawski, Osama Mawlawi, Jonathan McConathy, Alan McMillan, Julie C. Price, Abhejit Rajagopal, John Sunderland, Patrick Veit-Haibach, Kristen A Wangerin, Chunwei Ying and Thomas A. Hope

Journal of Nuclear Medicine July 22, 2021, jnumed.120.261881; DOI: https://doi.org/10.2967/jnumed.120.261881
You have access
Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study.
Manuel Röhrich, Dominik Leitz, Frederik M. Glatting, Annika K. Wefers, Oliver Weinheimer, Paul Flechsig, Nicolas Kahn, Markus A. Mall, Frederik L. Giesel, Clemens Kratochwil, Peter E. Huber, Andreas von Deimling, Claus Peter Heußel, Hans Ulrich Kauczor, Michael Kreuter and Uwe A. Haberkorn

Journal of Nuclear Medicine July 16, 2021, jnumed.121.261925; DOI: https://doi.org/10.2967/jnumed.121.261925
You have access
Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?
Jakoba J Eertink, Elisabeth A.G Pfaehler, Sanne E Wiegers, Tim van de Brug, Pieternella J Lugtenburg, Otto S Hoekstra, Josee M Zijlstra, Henrica C.W de Vet and Ronald Boellaard

Journal of Nuclear Medicine July 16, 2021, jnumed.121.262117; DOI: https://doi.org/10.2967/jnumed.121.262117
You have access
¹⁸F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma
Matthias R. Benz, Wesley R. Armstrong, Francesco Ceci, Giulia Polverari, Timothy R. Donahue, Zev A. Wainberg, Andrew Quon, Martin Auerbach, Mark D. Girgis, Ken Herrmann, Johannes Czernin and Jeremie Calais

Journal of Nuclear Medicine July 16, 2021, jnumed.121.261952; DOI: https://doi.org/10.2967/jnumed.121.261952
You have access
Dosimetric quantities of neuroendocrine tumors over treatment cycles with ¹⁷⁷Lu-DOTA-TATE
Daniel Roth, Johan Ruben Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner

Journal of Nuclear Medicine July 16, 2021, jnumed.121.262069; DOI: https://doi.org/10.2967/jnumed.121.262069
You have access
Safety of PSMA-targeted molecular radioligand therapy with ¹⁷⁷Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312
Jeremie Calais, Johannes Czernin, Pan Thin, Jeannine Gartmann, Kathleen Nguyen, Wesley R. Armstrong, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, Magnus Dahlbom, Beile He, Rouzbeh Esfandiari, David Ranganathan, Ken Hermann, Matthias Eiber, Wolfgang P Fendler and Ebrahim Delpassand

Journal of Nuclear Medicine July 16, 2021, jnumed.121.262543; DOI: https://doi.org/10.2967/jnumed.121.262543

Main menu

User menu

Search

More articles from Clinical Investigations (Human)

Pages